Evidence map›Paper›PMID 29228623›Full record

ArticleOncotarget2017

Linking CREB function with altered metabolism in murine fibroblast-based model cell lines.

André Steven, Sandra Leisz, Claudia Wickenhauser, Kristin Schulz, Dimitrios Mougiakakos, Rolf Kiessling, Carsten Denkert, Barbara Seliger

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. cAMP response element-binding protein: A credible cancer drug target.The Journal of pharmacology and experimental therapeutics · 2025
    Review
  3. Deletion of Slc9a1 in Cx3cr1Journal of neuroinflammation · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. What turns CREB on? And off? And why does it matter?Cellular and molecular life sciences : CMLS · 2020
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

André StevenInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Sandra LeiszInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Claudia WickenhauserInstitute of Pathology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Kristin SchulzInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Dimitrios MougiakakosDepartment of Internal Medicine 5, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany.
Rolf KiesslingKarolinska Institute, CCK, Stockholm, Sweden.
Carsten DenkertCharité Berlin, Institute of Pathology, Berlin, Germany.
Barbara SeligerInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Martin Luther University Halle-Wittenberg · DECharité - Universitätsmedizin Berlin · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cAMP-responsive element binding protein CREB is frequently overexpressed and activated in tumors of distinct histology, leading to enhanced proliferation, migration, invasion and angiogenesis as well as reduced apoptosis. The de-regulated expression of CREB might be linked with transcriptional as well as post-transcriptional regulation mechanisms. We show here that altered CREB expression levels and function are associated with changes in the cellular metabolism. Using comparative proteome-based analysis an altered expression pattern of proteins involved in the cellular metabolism in particular in glycolysis was found upon CREB down-regulation in HER-2/neu-transfected cell lines. This was associated with diminished expression levels of the glucose transporter 1, reduced glucose uptake and reduced glycolytic activity in HER-2/neu-transfected cells with down-regulated CREB when compared to HER-2/neu

Indexed as

CREBHER-2/neumetabolismmitochondriaROS

Identifiers

PMID29228623
PMCPMC5722575
OpenAlexW2766326937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.